ALPHAMER TECHNOLOGY
ALPHAMER TECHNOLOGY
Industry:
Biotechnology Health Care Information Technology Pharmaceutical
Founded:
2010-01-01
Status:
Active
Technology used in webpage:
ReCAPTCHA U.S. Server Location Gravity Forms
Similar Organizations
Ability Pharmaceuticals
Ability Pharmaceuticals is a drug discovery and development company.
ARX Technologies
Technology based startup involves research and development of embedded systems
Cal-BRAIN
A Neurotechnology Program for California.
Coelacanth
Coelacanth, which uses proprietary chemistry technologies to rapidly discover new chemical entities for drug development.
Directional Healthcare Advisors, LLC
Healthcare technology management and commercialization
Illumigen Biosciences
Illumigen Biosciences is drug discovery and development firm.
Proteomedix Frontiers
Proteomedix Frontiers is drug discovery and development company.
More informations about "Alphamer technology"
Alphamer technology - Crunchbase Company Profile & Funding
Alphamer technology for drug discovery and development platform? Acquired by . Centauri Therapeutics . Private; 2,972,607; Highlights. Similar Companies 7. ... 3,629 Number of …See details»
Immunotherapy focused on infectious diseases
Mar 4, 2025 Centauri Therapeutics is an immunotherapy company currently focused on infectious diseases and oncology. Centauri’s approach to treating infectious diseases rests upon proprietary Alphamer ® technology. All projects …See details»
Alphamer Technology gets Seed Fundraising to Fight …
Feb 20, 2017 An alphamer is composed of a DNA aptamer (purple) and an alpha-galactose sugar (blue) The alphamer technology was initially developed …See details»
Pipeline - Centauri Therapeutics Limited
Centauri has developed a pipeline of novel therapeutic candidates based on our proprietary Alphamer® platform. Our current focus is on developing novel treatments for infectious diseases, however the Alphamer® platform also has …See details»
Centauri Therapeutics Acquires Alphamer Technology from …
Jan 18, 2016 Alphamer technology is based on chemically synthesized molecules redirecting naturally occurring antibodies to selected pathogens to fight infection—what the company calls …See details»
Centauri acquires Alphamer technology from Altermune
Jan 18, 2016 Clive Dix, Chairman of Centauri Therapeutics, added: “The Alphamer platform technology is a unique opportunity to assemble well-characterised building blocks to produce novel and IP-protected medicines. …See details»
BRIEF—Centauri given $1.25m to advance antimicrobials
Nov 25, 2024 Centauri Therapeutics secured a £1 million ($1.25 million) grant from PACE to advance its Alphamer technology, targeting multidrug-resistant Gram-negative bacteria. The …See details»
Centauri Therapeutics buys Alphamer immuno-therapeutics …
Jan 18, 2016 Centauri Therapeutics has bought Alphamer technology from Altermune Technologies for an undisclosed amount, for drug discovery and development. The company …See details»
Alphamer Technology - Ownership and Business Overview | Mergr
Jan 18, 2016 Alphamer Technology is a life science company. Life Science M&A Summary in 2016 Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016 .See details»
UK’s Peakdale signs agreement with Centauri for Alphamer …
Jul 12, 2016 The Alphamer technology is based on programmable immunity, in which chemically synthesised molecules redirect naturally occurring antibodies to selected pathogens in order to …See details»
Alphamer technology - Drug pipelines, Patents, Clinical trials
Explore Alphamer technology with its drug pipeline, therapeutic area, technology platform, . Explore Alphamer technology with its drug pipeline, therapeutic area, technology platform, . …See details»
Alphamer technology acquired by Centauri Therapeutics
Alphamer technology Alphamer technology for drug discovery and development platform? Acquiring Organization: Centauri Therapeutics Centauri Therapeutics is a UK-based …See details»
Alphamer technology - Tech Stack, Apps, Patents & Trademarks
Alphamer technology for drug discovery and development platform?See details»
Centauri Therapeutics Closes £24 Million GBP Series A Investment …
Feb 16, 2022 Centauri is leveraging the Alphamer technology to introduce an innovative drug mechanism that recruits and directs pre-existing antibodies specifically to pathogens, …See details»
Novo Holdings REPAIR Impact Fund invests in Centauri Therapeutics
Feb 16, 2022 Centauri is leveraging the Alphamer technology to introduce an innovative drug mechanism that recruits and directs pre-existing antibodies specifically to pathogens, …See details»
Centauri Therapeutics Ltd to Develop Novel Anti-Infective …
Jan 21, 2016 Clive Dix, Chairman of Centauri Therapeutics, said: "The Alphamer platform technology is a unique opportunity to assemble well-characterised building blocks to produce …See details»
ALTERMUNE’S ALPHAMERS
The alphamer technology was patented by Mullis and the patent was assigned to Altermune. The company has rights to develop the technology for all indications including cancer. Agalimmune …See details»
Horizon, Centauri form joint venture to move Alphamer …
Mar 3, 2016 DUBLIN – Avvinity Therapeutics Ltd., a newly created joint venture between Horizon Discovery Group plc and start-up firm Centauri Therapeutics Ltd., is getting up to £5.3 …See details»
'Alphamer' Centauri: Start-up taking over anti-infective platform
Jan 20, 2016 LONDON – U.K. newco Centauri Therapeutics Ltd. has acquired the alphamer anti-infective technology inspired by Nobel Laureate and inventor of the polymerase chain …See details»
Avvinity activates | Drug Discovery News
Mar 2, 2016 The Alphamer technology is based on chemically synthesized molecules that redirect naturally occurring antibodies in the human immune system to target pathogens or …See details»